|
28/11/2017 |
Bioequivalence of Phenytoin |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Diltiazem retard |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Sildenafil |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Digoxin |
CIDEM |
Registered |
|
28/11/2018 |
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
ABOCA |
Registered outdated |
|
28/12/2018 |
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
CIM |
Registered outdated |
|
29/01/2016 |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
CIM |
Registered |
|
29/02/2024 |
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
CATALYSIS |
Registered |
|
29/05/2020 |
Biomodulina T - IM - covid-19 - older adult |
BIOCEN |
Registered |
|
29/05/2020 |
Heberon Alfa R in COVID-19 |
MINSAP_AM |
Registered outdated |
|
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
|
29/09/2017 |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
CENSA |
Registered |
|
29/10/2021 |
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
CIGB |
Registered |
|
29/11/2017 |
Bioequivalence of Zidovudine |
CIDEM |
Registered |
|
29/12/2016 |
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain |
FINLAY |
Registered |
|
30/01/2018 |
Bioequivalence of Trienor |
CIDEM |
Registered |
|
30/01/2023 |
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
DIRECCION DE INVESTIGACION UCE |
Registered |
|
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
|
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
|
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
